Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells
Authors
Keywords
Pancreatic cancer, Gemcitabine, Valproic acid, Combined chemotherapy, Bmi1
Journal
Cell and Bioscience
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-18
DOI
10.1186/s13578-019-0312-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter
- (2018) Torben Redmer Molecular Cancer
- TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Phosphorylation on S727
- (2018) Vincent Drubay et al. Cancers
- Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
- (2017) Karoline V. Gleixner et al. HAEMATOLOGICA
- Dioscin Induces Gallbladder Cancer Apoptosis by Inhibiting ROS-Mediated PI3K/AKT Signalling
- (2017) Xiaoling Song et al. International Journal of Biological Sciences
- Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells
- (2017) Subbroto Saha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells
- (2017) Hengqiang Zhao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- BMI1, a new target of CK2α
- (2017) Soumyajit Banerjee Mustafi et al. Molecular Cancer
- Adverse Event Reporting in Clinical Trials: Time to Include Duration as Well as Severity
- (2017) Oliver Sartor ONCOLOGIST
- Cr(VI) induces cytotoxicity in vitro through activation of ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction via the PI3K/Akt signaling pathway
- (2017) Yujing Zhang et al. TOXICOLOGY IN VITRO
- Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells
- (2017) Maria Saveria Gilardini Montani et al. CELLULAR ONCOLOGY
- Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
- (2017) Karoline V. Gleixner et al. HAEMATOLOGICA
- The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3
- (2017) Lulu Ni et al. Scientific Reports
- Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
- (2016) Elena Ceccacci et al. BRITISH JOURNAL OF CANCER
- Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade
- (2016) Zhengle Zhang et al. CANCER LETTERS
- Hypoxia-inducible factor-targeting prodrug TOP3 combined with gemcitabine or TS-1 improves pancreatic cancer survival in an orthotopic model
- (2016) Ngoc Thi Hong Hoang et al. CANCER SCIENCE
- Epidemiology of pancreatic cancer
- (2016) Milena Ilic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells
- (2015) Heng Yang et al. CANCER RESEARCH
- Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer
- (2015) Nagaraj S. Nagathihalli et al. GASTROENTEROLOGY
- Cycling hypoxia induces chemoresistance through the activation of reactive oxygen species-mediated B-cell lymphoma extra-long pathway in glioblastoma multiforme
- (2015) Wei-Ling Chen et al. Journal of Translational Medicine
- HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells
- (2015) MEIYING JI et al. ONCOLOGY REPORTS
- The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX
- (2015) Yufeng Wang et al. Targeted Oncology
- Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer
- (2014) Lucas de Sousa Cavalcante et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- An Undesired Effect of Chemotherapy
- (2013) Sumit Arora et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells
- (2013) Atsushi Sato et al. Stem Cell Research
- Histone deacetylase inhibitor induction of epithelial–mesenchymal transitions via up-regulation of Snail facilitates cancer progression
- (2012) Guan-Min Jiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells
- (2011) Shuichi Iwahashi et al. International Journal of Clinical Oncology
- Bmi-1 is related to proliferation, survival and poor prognosis in pancreatic cancer
- (2010) Wenjie Song et al. CANCER SCIENCE
- A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
- (2010) Jaime Coronel et al. MEDICAL ONCOLOGY
- Advanced pancreatic carcinoma: current treatment and future challenges
- (2010) Anastasios Stathis et al. Nature Reviews Clinical Oncology
- Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer
- (2010) Soley Bayraktar WORLD JOURNAL OF GASTROENTEROLOGY
- STAT3 as a Central Regulator of Tumor Metastases
- (2009) Eswaran Devarajan et al. CURRENT MOLECULAR MEDICINE
- Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions
- (2009) Roland Andersson et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started